[1]
“A Comprehensive Review on the Nanocarrier-based Drug Delivery of Cabazitaxel”, Int. J. Pharm. Sci. Drug Res., vol. 14, no. 5, pp. 646–652, Sep. 2022, doi: 10.25004/IJPSDR.2022.140520.